SEL120–34A, a specific, potent and orally bioavailable...

European Journal of Cancer 2016 / 12 Vol. 69

SEL120–34A, a specific, potent and orally bioavailable inhibitor of CDK8, targets STAT-dependent gene transcription in leukemia and lymphoma models

Zylkiewicz, E., Rzymski, T., Mikula, M., Dreas, A., Wiklik, K., Wrobel, A., Golas, A., Dolata, I., Wojcik, K., Masiejczyk, M., Statkiewicz, M., Kuklinska, U., Goryca, K., Grochowsk, A., Cabaj, A., Bia
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
69
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/S0959-8049(16)32992-6
Date:
December, 2016
File:
PDF, 51 KB
english, 2016
Conversion to is in progress
Conversion to is failed